Skip to main content
Figure 3 | Malaria Journal

Figure 3

From: Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling

Figure 3

Predicted dihydroartemisinin-piperaquine treatment outcome per age group (in years) in an African population of 10,000 individuals dosed by (A) age or (B) weight (i e, patients receive one dose daily over three days given at 0 h, 24 h and 48 h). Black triangles indicate the cut-off points of the age-based dosing bands.

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us